Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna Axonics, Inc. Transaction History

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna

$249 Billion
Q2 2025

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Aug 29, 2025	BUY	$67.3 - $69.67 $619,160 - $640,964	9,200 New	9,200 $640 Million
Q1 2024 Aug 29, 2025	BUY	$56.67 - $69.36 $521,364 - $638,112	9,200 New	9,200 $608 Million
Q4 2023 Sep 02, 2025	BUY	$49.38 - $63.75 $454,296 - $586,500	9,200 New	9,200 $573 Million

Others Institutions Holding AXNX

# of Institutions

Shares Held

4.99M

Call Options Held

Put Options Held

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna, based on Form 13F filings with the SEC.

News

Stay updated on Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna with notifications on news.

Account